A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

Long-term clinical trials show patients with stage four kidney cancer are living a decade or more beyond previous ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

Johnson & Johnson received approval from the Food and Drug Administration for a treatment for certain patients with multiple myeloma, an incurable form of blood cancer. The healthcare conglomerate ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.

Chronically high levels of insulin and inflammation are key features of obesity and metabolic syndrome, which mediate cancer ...

Research conducted by Gustave Roussy will help StarkAge move STX-01, an antibody-drug conjugate targeting senescent cells, toward clinical trials.

Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy ...